Dr. Caroline M. Apovian, MD

Dr. Apovian practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Apovian's NPI, 1346205606, was assigned on April 19, 2006. Dr. Apovian graduated from Rutgers New Jersey Medical School in 1985. Dr. Apovian's Massachusetts license number on file is 59331.

Dr. Apovian's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Apovian's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Apovian to 1 more group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Apovian practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Apovian's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Apovian is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Apovian's licenses on file in 6 states: Massachusetts, Florida, New Hampshire, Rhode Island, Maine and Pennsylvania.

Dmand AI lists atrial fibrillation and flutter, chronic diabetes, chronic hypertension, diabetic emergency, fatty liver, heart valve disorders, high cholesterol and obesity among the conditions Dr. Apovian treats.

CMS data shows 121 Medicare services from Dr. Apovian across 2 procedure codes in 2024, all of them office visits, for 120 Medicare patients. Medicare paid $15,641 for them. Every service was in an office.

CMS counts 120 Medicare patients who saw Dr. Apovian in 2024. The largest group is 65 to 74, with 63 patients. 74% of them have high blood pressure, and 71% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Apovian's median patient age at 57, with 74% women.

In 2024, Dr. Apovian wrote 824 Medicare Part D claims for 144 patients. CMS names the drug for 757 of them, across 10 drugs with 11 or more claims each, at $589,697 in total drug cost. In 2023, CMS named 773 claims across 9 drugs.

Dr. Apovian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Apovian as offering telehealth.

Dmand AI links 150 papers to Dr. Apovian, published from 2008 to 2025. 2017 was the busiest year, with 7. The most frequent topics are Obesity, Weight Loss and Body Mass Index. Dr. Apovian has published most often in Obesity (Silver Spring). Dr. Apovian's most frequent co-authors are Louis Joseph Aronne, MD, Donald T. Hess, MD and Noyan A. Gokce, MD.

Dmand AI links Dr. Apovian to 10 clinical trials, 2 of them phase 1 studies. Conditions studied include Obesity, Overnutrition and Weight Loss. Boston Medical Center sponsors the most, 6.

CMS Open Payments shows 140 general payments to Dr. Apovian from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. Novo Nordisk Inc paid the most, $79,926.

Dmand AI lists 1 award for Dr. Apovian, most recently Regional Top Doctor in 2014. Dr. Apovian serves on Pharmacological Management of Obesity Guideline Task Force The Endocrine Society.

Dr. Apovian graduated from Rutgers New Jersey Medical School in 1985.

Dr. Apovian is in network with 13 carriers, including Aetna, United Healthcare and Elevance. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.